Morgan Stanley: 2 Stocks That Could Climb Over 40%, , on October 12, 2020 at 2:41 pm

Financial News
By
On October 12, 2020
In Financial News
Tags:

Since President Trump was released from the hospital, following his bout with the coronavirus, the headlines have turned towards the possibility of a new economic stimulus package. On both sides of the aisle, there’s a perception that the public needs this – support for unemployment benefits, support for small businesses, more cash injected into the system – as a new wave of COVID cases starts ramping up.The stumbling block is partisan politics. House Democrats put together a $2.2 trillion proposal, but it was loaded down with the traditional Congressional pork: plenty of funds for majority party pet projects, that would not likely get funded otherwise. Trump, with support from Congressional Republicans, refused to accept it. The Democrats refused to back down. Both sides are now refusing to negotiate. The media wisdom is, this is a political defeat for the President in the run-up to the election.But, however the political optics work out, the economy may survive without this life support, according to equity strategist Mike Wilson of Morgan Stanley.“I don’t think we need stimulus in the next 30 days for the economy to stay afloat. There is no risk of a double dip recession in the next 30 days if we don’t get the stimulus done,” Wilson wrote.In the longer run, Wilson is optimistic that a stimulus package will happen. He notes that it is in the interests of both political parties to pass it, and adds, “We still think stimulus is coming. It is now just a timing question before or after the election. Our best guess is probably after the election.”Following Wilson’s lead, Morgan Stanley analysts are pounding the table on two stocks that look especially compelling. According to these analysts, each name is poised to surge at least 40% over the 12 months ahead. We ran the the two through TipRanks database to see what other Wall Street’s analysts have to say about them.Ferrari NV (RACE)We’ll start in the fast lane, with Ferrari. The famous performance and luxury car company has performed well this year, recovering quickly from the mid-winter corona-inspired market crash. The recovery in RACE shares underlines the fact that Ferrari’s well-heeled customer base is largely immune to downturns in consumer spending.Adam Jonas, Morgan Stanley’s expert in the automotive industry, sees Ferrari in a solid position as the year-end checkered flag approaches.“We believe the 5 new 2020 models plus the 2 to be released in 2021 (1 yet to be announced) mean Ferrari is poised for an extreamly strong 2021 from the point of view of overall: portfolio diversification, mix and higher ASPs, which together with strong economies of scale, can lead investors to expect strong incremental margins. We forecast EBITDA margins to rise from 32% in 2020 to 36% in 2021 (34% in 2019),” Jonas wrote. To this end, Jonas rates the stock as Overweight (i.e. Buy), supported by those comments, and his $265 price target suggests a one-year upside of 44%. (To watch Jonas’ track record, click here)Overall, Ferrari stock has a Moderate Buy rating from the analyst consensus, with 11 reviews breaking down to 9 Buys, 1 Hold, and 1 Sell. The shares are selling for $184.48, and their $210.03 average price target suggests they have a 14% upside potential for the year ahead. (See RACE stock analysis on TipRanks)Delta Airlines, Inc. (DAL)Next up is Delta Airlines, one of the major players in the global airlines industry. With its headquarters and primary hub in Atlanta, Georgia, Delta boasts a market cap of almost $21 billion – and that’s after accounting for the stock’s net loss of 44% since the end of February.The airline industry has been pummeled by the trade and travel restrictions put in place to combat coronavirus, in addition to the slow demand due to the economic crisis. DAL reported just $1.47 billion in revenue for Q2, down 82% sequentially, and the EPS loss was deep, at $4.43. The company has been taking steps to maintain liquidity, including issuing senior secured notes for upwards of $1.5 billion and drawing on a $3 billion credit facility.Morgan Stanley’s Ravi Shanker focuses on the airline industry, and describes recent conditions as a “long and tough quarter.” However, the analyst the analyst views DAL’s risk-reward as compelling at current levels”We expect a beat for DAL this quarter, but don’t believe that results (outside of cash burn) are likely to matter… We expect investors to focus on forward commentary more than current results,” Shanker noted. “DAL has some of the strongest customer satisfaction numbers among the other Legacy peers, while also commanding a higher PRASM, making it our preferred Legacy carrier. With ample liquidity we see limited liquidity risk here.”In line with his view of Delta as fundamentally sound, Shanker rates the stock Overweight (i.e Buy). He sets a price target of $54, indicating confidence in an impressive upside of 65% for the coming year. (To watch Shanker’s track record, click here)Overall, the analyst consensus view for DAL is a Moderate Buy, based on 11 reviews, including 7 Buys and 4 Holds. The average target of $39.50 suggests a one-year upside of 20% from the current share price of $32.73. (See DAL stock analysis at TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.,

Morgan Stanley: 2 Stocks That Could Climb Over 40%Since President Trump was released from the hospital, following his bout with the coronavirus, the headlines have turned towards the possibility of a new economic stimulus package. On both sides of the aisle, there’s a perception that the public needs this – support for unemployment benefits, support for small businesses, more cash injected into the system – as a new wave of COVID cases starts ramping up.The stumbling block is partisan politics. House Democrats put together a $2.2 trillion proposal, but it was loaded down with the traditional Congressional pork: plenty of funds for majority party pet projects, that would not likely get funded otherwise. Trump, with support from Congressional Republicans, refused to accept it. The Democrats refused to back down. Both sides are now refusing to negotiate. The media wisdom is, this is a political defeat for the President in the run-up to the election.But, however the political optics work out, the economy may survive without this life support, according to equity strategist Mike Wilson of Morgan Stanley.“I don’t think we need stimulus in the next 30 days for the economy to stay afloat. There is no risk of a double dip recession in the next 30 days if we don’t get the stimulus done,” Wilson wrote.In the longer run, Wilson is optimistic that a stimulus package will happen. He notes that it is in the interests of both political parties to pass it, and adds, “We still think stimulus is coming. It is now just a timing question before or after the election. Our best guess is probably after the election.”Following Wilson’s lead, Morgan Stanley analysts are pounding the table on two stocks that look especially compelling. According to these analysts, each name is poised to surge at least 40% over the 12 months ahead. We ran the the two through TipRanks database to see what other Wall Street’s analysts have to say about them.Ferrari NV (RACE)We’ll start in the fast lane, with Ferrari. The famous performance and luxury car company has performed well this year, recovering quickly from the mid-winter corona-inspired market crash. The recovery in RACE shares underlines the fact that Ferrari’s well-heeled customer base is largely immune to downturns in consumer spending.Adam Jonas, Morgan Stanley’s expert in the automotive industry, sees Ferrari in a solid position as the year-end checkered flag approaches.“We believe the 5 new 2020 models plus the 2 to be released in 2021 (1 yet to be announced) mean Ferrari is poised for an extreamly strong 2021 from the point of view of overall: portfolio diversification, mix and higher ASPs, which together with strong economies of scale, can lead investors to expect strong incremental margins. We forecast EBITDA margins to rise from 32% in 2020 to 36% in 2021 (34% in 2019),” Jonas wrote. To this end, Jonas rates the stock as Overweight (i.e. Buy), supported by those comments, and his $265 price target suggests a one-year upside of 44%. (To watch Jonas’ track record, click here)Overall, Ferrari stock has a Moderate Buy rating from the analyst consensus, with 11 reviews breaking down to 9 Buys, 1 Hold, and 1 Sell. The shares are selling for $184.48, and their $210.03 average price target suggests they have a 14% upside potential for the year ahead. (See RACE stock analysis on TipRanks)Delta Airlines, Inc. (DAL)Next up is Delta Airlines, one of the major players in the global airlines industry. With its headquarters and primary hub in Atlanta, Georgia, Delta boasts a market cap of almost $21 billion – and that’s after accounting for the stock’s net loss of 44% since the end of February.The airline industry has been pummeled by the trade and travel restrictions put in place to combat coronavirus, in addition to the slow demand due to the economic crisis. DAL reported just $1.47 billion in revenue for Q2, down 82% sequentially, and the EPS loss was deep, at $4.43. The company has been taking steps to maintain liquidity, including issuing senior secured notes for upwards of $1.5 billion and drawing on a $3 billion credit facility.Morgan Stanley’s Ravi Shanker focuses on the airline industry, and describes recent conditions as a “long and tough quarter.” However, the analyst the analyst views DAL’s risk-reward as compelling at current levels”We expect a beat for DAL this quarter, but don’t believe that results (outside of cash burn) are likely to matter… We expect investors to focus on forward commentary more than current results,” Shanker noted. “DAL has some of the strongest customer satisfaction numbers among the other Legacy peers, while also commanding a higher PRASM, making it our preferred Legacy carrier. With ample liquidity we see limited liquidity risk here.”In line with his view of Delta as fundamentally sound, Shanker rates the stock Overweight (i.e Buy). He sets a price target of $54, indicating confidence in an impressive upside of 65% for the coming year. (To watch Shanker’s track record, click here)Overall, the analyst consensus view for DAL is a Moderate Buy, based on 11 reviews, including 7 Buys and 4 Holds. The average target of $39.50 suggests a one-year upside of 20% from the current share price of $32.73. (See DAL stock analysis at TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage